Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: New Patent 336 Entry Under Transaction Description

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

New Patent 336 Entry Under Transaction Description

hotflame

Jun 17, 2009 07:09AM

Re: New Patent 336 Entry Under Transaction Description

bigdetfan

Jun 17, 2009 07:13AM

Re: New Patent 336 Entry Under Transaction Description

1Rare1

Jun 17, 2009 07:16AM

Re: New Patent 336 Entry Under Transaction Description

bigdetfan

Jun 17, 2009 07:31AM

Re: New Patent 336 Entry Under Transaction Description

1Rare1

Jun 17, 2009 07:44AM

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New Patent 336 Entry Under Transaction Description

in response to

Re: New Patent 336 Entry Under Transaction Description

1Rare1

posted on Jun 17, 2009 07:46AM

The request has been accepted - same phrase ("Notice of Reexam Published in Official Gazette.") with every patent, where the re-ex starts...

One should think there could be no more "new" patents which question the 336 after all these years of examination - what are these guys at the UPSTO doing?

GLTA

1 Recommendations